Questions: Translation Elongation and Termination: Peptide Bond Formation

5 questions to test your understanding

Score: 0 / 5
Question 1 Multiple Choice

A drug blocks peptide bond formation during translation without affecting tRNA delivery, GTP hydrolysis, or translocation. What is the drug's most likely target?

AEF-Tu, the elongation factor that delivers aminoacyl-tRNAs to the A site
BThe peptidyl transferase center — specifically the 23S (or 28S) rRNA that catalyzes the reaction
CEF-G, the translocase that moves tRNAs and mRNA by one codon
DA ribosomal protein enzyme in the large subunit that stabilizes the transition state
Question 2 Multiple Choice

What is the function of GTP hydrolysis by EF-Tu during aminoacyl-tRNA delivery, and why does it improve accuracy beyond what base pairing alone achieves?

AGTP hydrolysis provides energy to force the aminoacyl-tRNA into the A site against electrostatic repulsion
BGTP hydrolysis triggers a conformational change that releases EF-Tu only after correct codon-anticodon pairing is verified, allowing incorrect tRNAs to dissociate before accommodation — kinetic proofreading
CGTP hydrolysis powers translocation of the ribosome by one codon after delivery is complete
DGTP hydrolysis activates the aminoacyl-tRNA by phosphorylating the amino acid before peptide bond formation
Question 3 True / False

When a stop codon enters the A site of the ribosome, termination is triggered by a release factor that structurally mimics a tRNA.

TTrue
FFalse
Question 4 True / False

Peptide bond formation in the ribosome is catalyzed by a protein enzyme called peptidyl transferase, which is encoded by a ribosomal protein gene.

TTrue
FFalse
Question 5 Short Answer

Explain how kinetic proofreading by EF-Tu achieves an error rate far lower than codon-anticodon base pairing alone could provide.

Think about your answer, then reveal below.